Literature DB >> 14553875

Autoimmune aspects of cytokine and anticytokine therapies.

Irit Krause1, Guido Valesini, Rossana Scrivo, Yehuda Shoenfeld.   

Abstract

Cytokines and anticytokines are used increasingly in the treatment of immune, autoimmune, inflammatory, infectious, and malignant disorders. Commonly used treatments include the anti-tumor necrosis factor agents interferon alpha, interferon beta, interferon gamma, and interleukin 2. Several autoimmune phenomena have been reported in patients treated with these substances. This review summarizes the published data on the autoimmune manifestations associated with cytokine and anticytokine therapies, as well as describes possible mechanisms of these phenomena.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14553875     DOI: 10.1016/s0002-9343(03)00390-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  26 in total

1.  Effect of TNF-α production inhibitors on the production of pro-inflammatory cytokines by peripheral blood mononuclear cells from HTLV-1-infected individuals.

Authors:  T Luna; S B Santos; M Nascimento; M A F Porto; A L Muniz; E M Carvalho; A R Jesus
Journal:  Braz J Med Biol Res       Date:  2011-10-22       Impact factor: 2.590

Review 2.  Hepatitis C and interferon induced thyroiditis.

Authors:  Yaron Tomer
Journal:  J Autoimmun       Date:  2010-05       Impact factor: 7.094

Review 3.  Interferon alpha: The key trigger of type 1 diabetes.

Authors:  Angela Lombardi; Effie Tsomos; Sara S Hammerstad; Yaron Tomer
Journal:  J Autoimmun       Date:  2018-08-14       Impact factor: 7.094

4.  Salivary and serum interleukin-18 in patients with oral lichen planus: a study in an ethnic Chinese population.

Authors:  Yuanyuan Zhang; Wenzhao Liu; Songtao Zhang; Hongxia Dan; Rui Lu; Fang Wang; Jing Wang; Min Zhou; Xin Zeng; Mei Lin; Qianming Chen; Yu Zhou
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

5.  Interleukin-10 in murine metal-induced systemic autoimmunity.

Authors:  B Häggqvist; P Hultman
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

6.  Blood serum levels of proinflammatory cytokines in patients with different degrees of biliary pancreatitis.

Authors:  Józefa Panek; Danuta Karcz; Rrichard Pieton; Jakub Zasada; Marcin Tusinski; Miroslaw Dolecki; Marek Winiarski
Journal:  Can J Gastroenterol       Date:  2006-10       Impact factor: 3.522

Review 7.  Vitamin D and chronic hepatitis C: effects on success rate and prevention of side effects associated with pegylated interferon-α and ribavirin.

Authors:  Bassem Refaat; Adel Galal El-Shemi; Ahmed Ashshi; Esam Azhar
Journal:  Int J Clin Exp Med       Date:  2015-07-15

Review 8.  Interferon alpha treatment and thyroid dysfunction.

Authors:  Yaron Tomer; Jason T Blackard; Nagako Akeno
Journal:  Endocrinol Metab Clin North Am       Date:  2007-12       Impact factor: 4.741

9.  Treatment of chronic hepatitis C in a patient affected by systemic sclerosis.

Authors:  Guido Poggi; Laura Villani; Federico Sottotetti; Barbara Tagliaferri; Benedetta Montagna; Alessio Amatu; Giovanni Bernardo
Journal:  Gastroenterol Res Pract       Date:  2009-11-17       Impact factor: 2.260

Review 10.  Interferon induced thyroiditis.

Authors:  Yaron Tomer; Francesca Menconi
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2009-12       Impact factor: 4.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.